Apogenix.com
Visit apogenix.com-
10 months ago
Last scanned
-
24 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Apogenix.com
Visit apogenix.com
About Website
Updated:
Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer and other malignant diseases
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
Network Data
This website is hosted with 1&1 IONOS SE, which reserves the following IP addresses for apogenix.com: 217.160.0.147. Moreover, DNS used with this website include ns1037.ui-dns.biz, ns1037.ui-dns.com, ns1037.ui-dns.de, ns1037.ui-dns.org.
-
10 months ago
Last scanned
-
24 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ns1037.ui-dns.biz
ns1037.ui-dns.com
ns1037.ui-dns.de
ns1037.ui-dns.org
Whois
OWNERSHIP
-
Created
1999-11-30
-
Expires
2023-11-30
-
Owner
-
Registar
IONOS SE
-
Owner Emails
dataprivacyprotected@ionos.de
Domain & Keywords
The registrar of apogenix.com is IONOS SE and the name expires on 2023-11-30. According to open source data, you can reach the owner at dataprivacyprotected@ionos.de but please make sure you have a good reason for unsolicited messages. Their country of residence is Germany.
- research
- Hematology
- brain tumor
- oncology
- Immunotherapy
- oncological
- apogenix
- hematological
- solid tumors
- Phase II Trial
Websites similar to apogenix.com
-
apogenix.de-
Global rank
N/A
-
Daily Visitors
N/A
-
-
starhi.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
llcg.be-
Global rank
N/A
-
Daily Visitors
N/A
-
-
poeticphase1.org-
Global rank
N/A
-
Daily Visitors
N/A
-
-
clinicalinvestigationcentre.com-
Global rank
N/A
-
Daily Visitors
N/A
-